Stimulants and polysubstance use, part 2: what prevention can do
Stimulant use and its consequences are a growing problem across much of the United States. Prevalence and fatal overdose rates were already increasing prior to the COVID-19 pandemic, and available data suggest these trends have worsened in the years since. Polysubstance use, particularly of opioids mixed with stimulants, has furthered increased the risks of use. This two-part webinar series will discuss the current data on these topics and evidence-based services prevention professionals can implement to address them. It also reviews risk and protective factors for stimulant use and how this current wave differs from past waves of stimulant use.
This webinar will discuss the status of evidence-based prevention services and programs for stimulant and polysubstance use. As part of this discussion, the webinar will review the similarities and differences between stimulant and opioid prevention and the current gaps in stimulant prevention research. The webinar will also discuss harm reduction strategies to address polysubstance use. Lastly, the webinar will provide recommendations for the future and a small group discussion opportunity for participants to share their own best practices.